ABHD5 Gene

Last updated on: 28.01.2022

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

The ABHD5 gene (ABHD5 stands for Abhydrolase Domain Containing 5, Lysophosphatidic Acid Acyltransferase) is a protein coding gene located on chromosome 3p21.33. The protein encoded by this gene belongs to a large family of proteins defined by an alpha/beta hydrolase fold and contains three sequence motifs corresponding to a catalytic triad found in the esterase/lipase/thioesterase subfamily. It differs from other members of this subfamily in that its putative catalytic triad contains an asparagine instead of a serine residue. Associated metabolic pathways include lipoprotein metabolism and triacylglycerol biosynthesis.

General informationThis section has been translated automatically.

Coenzyme A-dependent lysophosphatidic acid acyltransferase catalyzes the transfer of an acyl group to a lysophosphatidic acid. Preferentially functions with 1-oleyl lysophosphatidic acid, followed by 1-palmitoyl lysophosphatidic acid, 1-stearoyl lysophosphatidic acid, and 1-arachidonoyl lysophosphatidic acid as lipid acceptors. Is involved in the differentiation of keratinocytes.

Mutations in this gene are associated with Chanarin-Dorfman syndrome, a triglyceride storage disorder with impaired oxidation of long-chain fatty acids.

LiteratureThis section has been translated automatically.

  1. Cakmak E et al (2012) Chanarin-Dorfman syndrome: A comprehensive review. Liver Int 41: 905-914.
  2. Yang A et al. (2020) Adipocyte lipolysis: from molecular mechanisms of regulation to disease and therapeutics. Biochem J 477: 985-1008.

Last updated on: 28.01.2022